Find breaking R&D articles
 Search Tips

Select Disease Area for Search
Oncology
Cancer Immunotherapy
Pain Therapeutics
Psychiatry
Neurodegenerative Disorders
Cardiovascular Disease
Metabolic Diseases
Inflammation
Infectious Diseases
Genitourinary Tract Disorders
Technology
Other searches
News
PharmaReports

What is R&DBase?
Breaking reports&news by mail

Powered by LeadDiscovery

Search sponsorsadd search to your site
Search Results from R&D Base-PharmaReports Channel
Found 10 items, now showing 1 - 10

<< Prev  |  Next >>   
NewRefineWeb
1. PharmaReports: Oncology
Chronic Leukemias - Curative Intent Raises the Bar Innovative ... MYELODYSPLASTIC SYNDROME - Therapy Area Pipeline Report LEUKEMIA - Therapy Area Pipeline Report BREAST CANCER
www.leaddiscovery.co.uk/reports/oncology/2/
 
2. PharmaReports: Cancer Immunotherapy
Market Potential Acute Leukemias - Persistent unmet needs confer significant ... Stakeholder Insight: Prostate Cancer Chronic Leukemias - Curative Intent Raises the Bar
www.leaddiscovery.co.uk/reports/cancer-immunotherapy/1/
 
3. PharmaReports: Cancer Immunotherapy
Market Potential Acute Leukemias - Persistent unmet needs confer significant ... Stakeholder Insight: Prostate Cancer Chronic Leukemias - Curative Intent Raises the Bar
www.leaddiscovery.co.uk/reports/cancer-immunotherapy/
 
4. PharmaReports: Cancer Immunotherapy
Market Potential Acute Leukemias - Persistent unmet needs confer significant ... Stakeholder Insight: Prostate Cancer Chronic Leukemias - Curative Intent Raises the Bar
www.leaddiscovery.co.uk/reports/cancer-immunotherapy
 
5. PharmaReports: Cancer Immunotherapy
Area Pipeline Report LEUKEMIA - Therapy Area Pipeline Report BREAST CANCER - Therapy Area Pipeline Report GASTRIC CANCER - Therapy Area Pipeline Report HEAD AND NECK CANCER -
www.leaddiscovery.co.uk/reports/cancer-immunotherapy/2/
 
6. PharmaReports: Oncology
Market Potential Acute Leukemias - Persistent unmet needs confer significant commercial opportunity Gastric Cancer - Targeted Therapies Home In On a Neglected Tumor Type
www.leaddiscovery.co.uk/reports/oncology/
 
7. PharmaReports: Oncology
Market Potential Acute Leukemias - Persistent unmet needs confer significant commercial opportunity Gastric Cancer - Targeted Therapies Home In On a Neglected Tumor Type
www.leaddiscovery.co.uk/reports/oncology/1/
 
8. PharmaReports: Oncology
Market Potential Acute Leukemias - Persistent unmet needs confer significant commercial opportunity Gastric Cancer - Targeted Therapies Home In On a Neglected Tumor Type
www.leaddiscovery.co.uk/reports/oncology
 
9. PharmaReports: Technology
Area Pipeline Report LEUKEMIA - Therapy Area Pipeline Report BREAST CANCER - Therapy Area Pipeline Report GASTRIC CANCER - Therapy Area Pipeline Report HEAD AND NECK CANCER -
www.leaddiscovery.co.uk/reports/technology/3/
 
10. PharmaReports: Technology
Market Potential Acute Leukemias - Persistent unmet needs confer significant commercial opportunity Gastric Cancer - Targeted Therapies Home In On a Neglected Tumor Type
www.leaddiscovery.co.uk/reports/technology/2/
 
<< Prev  |  Next >>   
NewRefineWeb

Site search technology by FreeFind.com
Webmasters: get your own site search engine

About R&D Base: LeadDiscovery's panel of industry experts scans PubMed on a weekly basis using a combination of keywords and intuition to select research considered to be of key importance to the drug development sector. R&D Base is our proprietary database of selected research. Content is divided into core therapeutic area and can be searched ad hoc through R&D base. Alternatively you can register to receive breaking content as it is published through DailyUpdates